Relay Therapeutics Inc is trading 4.05% down today at $14.68, giving back a portion of its sharp gains from June 2, 2026.
- No fresh company-specific news, clinical trial updates, or analyst rating changes have been reported as of June 4, 2026.
- The move appears to be normal volatility following recent upside rather than a reaction to new information, occurring as broader indices show mixed performance.
- Recent market coverage continues to focus on April 2026 trial-related volatility and long-term analyst upside targets.